GO:0015826 threonine transport: Amino Acid Transport Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015826 threonine transport describes the directed movement of the amino acid threonine across cellular membranes, a process mediated by specific transporter proteins.
• Threonine transport is essential for supplying cells with threonine for protein synthesis and other metabolic pathways, and its dysregulation is linked to various diseases.
• Multiple transport systems exist, including Na+-coupled systems in bacteria and system B in intestinal epithelium, each with distinct properties.
• The blood-brain barrier possesses specific threonine transport mechanisms that regulate threonine availability to the brain.
• Threonine transport can be regulated by phosphorylation events, as shown for the dopamine transporter where threonine 48 dephosphorylation upregulates transport velocity.
• Studying threonine transport involves techniques such as membrane vesicle assays, radiolabeled uptake, and CRISPR-based genetic models to dissect transporter function.
Description
Threonine is an essential amino acid that must be obtained from the diet or environment and transported into cells to support protein synthesis and various metabolic processes. The Gene Ontology term GO:0015826, threonine transport, defines the directed movement of threonine into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. This process is fundamental to cellular physiology and is mediated by specialized membrane proteins that ensure adequate intracellular threonine levels. Research into threonine transport has revealed diverse transport systems across different organisms and tissues, including Na+-coupled serine/threonine transporters in bacteria and unique systems in mammalian intestinal epithelium. Understanding these mechanisms is crucial for elucidating how cells acquire this essential nutrient and how defects in transport can contribute to disease. For instance, threonine transport across the blood-brain barrier is critical for neurotransmitter synthesis and brain function, while in cancer cells, altered amino acid transport supports rapid proliferation. Moreover, threonine transport is implicated in skin homeostasis and inflammation, highlighting its broader physiological significance. This article provides a comprehensive overview of threonine transport, covering its definition, mechanisms, key genes, regulation, disease associations, and research methodologies, with a focus on how CRISPR-based models can advance our understanding.
threonine transport At A Glance
| GO ID | GO:0015826 |
|---|---|
| GO term | threonine transport |
| Ontology | biological_process |
| Synonym | L-threonine transport |
| Major function | Mediates the movement of threonine across cellular membranes, essential for protein synthesis and metabolism |
| Related transport systems | Na+-coupled serine/threonine transport system in E. coli, system B in pig jejunal brush border, N-like system in murine leukemia cells |
| Tissues/Organisms | Bacteria, intestinal epithelium, blood-brain barrier, leukemia cells, skin |
| Regulation | Can be regulated by phosphorylation (e.g., dopamine transporter Thr48 dephosphorylation) |
| Disease relevance | Cancer, skin inflammation, neurological disorders |
What Is GO:0015826?
According to the QuickGO definition, threonine transport (GO:0015826) is the directed movement of threonine, (2R*,3S*)-2-amino-3-hydroxybutanoic acid, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. This biological process encompasses the translocation of threonine across biological membranes, which can occur through various transport systems, including sodium-coupled symporters and facilitated diffusion carriers. The term is synonymous with L-threonine transport and is a subtype of amino acid transport.
Why Is threonine transport Important in Cell Biology?
Threonine transport is vital for cellular function because threonine is an essential amino acid required for protein synthesis and is a precursor for other metabolites. The transport process ensures that cells can take up threonine from the extracellular environment, which is particularly important for tissues with high metabolic demands, such as the brain and rapidly proliferating cancer cells. Defects in threonine transport can lead to amino acid imbalances, affecting protein synthesis and cellular signaling. Furthermore, threonine transport systems are potential drug targets, as inhibiting threonine uptake could starve cancer cells or pathogens. Understanding the regulation of these transporters, such as through phosphorylation, provides insights into how cells adapt to changing nutritional conditions. Additionally, threonine transport across the blood-brain barrier is crucial for neurotransmitter synthesis and brain homeostasis, and its role in skin inflammation highlights its importance in immune responses.
• Threonine is an essential amino acid, and its transport is necessary for protein synthesis in all cells.
• Specific transport systems for threonine have been identified in bacteria, intestinal epithelium, and the blood-brain barrier, indicating specialized functions.
• Threonine transport in cancer cells, such as murine P388 leukemia cells, supports their rapid growth and survival.
• The blood-brain barrier threonine transport mechanism regulates threonine availability to the brain, impacting neurotransmitter production.
• Phosphorylation of transporters, like the dopamine transporter at threonine 48, can regulate transport velocity, linking threonine transport to signaling pathways.
• Threonine transport is involved in skin homeostasis and inflammation, suggesting a role in immune regulation.
• Bacterial threonine transport systems, such as the Na+-coupled serine/threonine transporter in Porphyromonas gingivalis, are potential antibiotic targets.
• The unique system B in pig jejunal brush border membrane vesicles highlights species-specific adaptations for threonine absorption.
• Studying threonine transport can reveal mechanisms of nutrient sensing and metabolic regulation.
• CRISPR-based genetic screens can identify novel genes involved in threonine transport and its regulation.
What Happens During threonine transport?
Substrate Recognition and Binding
In simple terms: The transporter protein recognizes and binds threonine on one side of the membrane.
Threonine transport begins with the specific recognition of L-threonine by a membrane transporter. These transporters exhibit stereospecificity, often distinguishing L-threonine from D-threonine and other amino acids. For example, the Na+-coupled serine/threonine transport system in Escherichia coli shows high affinity for L-threonine. In pig jejunal brush border membrane vesicles, system B mediates Na+-independent threonine transport with unique characteristics. The binding site of the transporter accommodates the threonine molecule, often through hydrogen bonding and electrostatic interactions. This step is crucial for ensuring that only threonine is transported, maintaining cellular amino acid homeostasis.
Translocation Across the Membrane
In simple terms: The transporter undergoes a conformational change to move threonine across the cell membrane.
After binding, the transporter undergoes a series of conformational changes that translocate threonine from one side of the membrane to the other. This process can be driven by the electrochemical gradient of ions, such as sodium, as seen in Na+-coupled transporters. For instance, the sodium ion-driven serine/threonine transport in Porphyromonas gingivalis utilizes the sodium motive force to drive uptake. In contrast, facilitative transporters mediate passive transport down the concentration gradient. The translocation step is often the rate-limiting step and can be regulated by post-translational modifications, such as phosphorylation.
Release of Threonine into the Cytoplasm
In simple terms: Once inside, the transporter releases threonine into the cell.
Following translocation, the transporter releases threonine into the cytoplasm or the opposite compartment. This release is triggered by a change in the transporter's affinity for threonine, often due to the dissociation of coupling ions or a conformational shift. The released threonine then becomes available for metabolic processes, including protein synthesis and one-carbon metabolism. In the blood-brain barrier, threonine transport across the endothelial cells ensures a supply of threonine to the brain. The efficiency of release can affect intracellular threonine concentrations and downstream signaling pathways.
Regulation of Transport Activity
In simple terms: The activity of threonine transporters can be turned up or down to meet cellular needs.
Threonine transport is regulated at multiple levels to adapt to cellular demands. Short-term regulation often involves post-translational modifications. For example, dephosphorylation of the human dopamine transporter at threonine 48 by protein phosphatase PP1/2A up-regulates transport velocity, demonstrating a direct link between phosphorylation and transport activity. Long-term regulation can occur through changes in gene expression of transporters. In cancer cells, such as murine P388 leukemia cells, the presence of an N-like amino acid transport system for threonine and glutamine suggests that transporter expression is tailored to support rapid proliferation. Additionally, metabolic pathways controlling skin homeostasis and inflammation may influence threonine transport to meet the demands of immune cells.
Key Genes Involved in GO:0015826 threonine transport
The following genes and proteins are known to be involved in threonine transport, based on experimental evidence from various organisms and cell types.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC1A4 | Neutral amino acid transporter, may transport threonine | Potential role in brain threonine uptake; mutations linked to neurological disorders |
| SLC1A5 | Neutral amino acid transporter, transports threonine and glutamine | Implicated in cancer metabolism; target for cancer therapy |
| SLC7A5 | L-type amino acid transporter, transports large neutral amino acids including threonine | Overexpressed in many cancers; involved in mTOR signaling |
| SLC7A8 | L-type amino acid transporter, transports threonine | Expressed in kidney and intestine; role in amino acid reabsorption |
| SLC6A14 | Na+- and Cl--dependent amino acid transporter, transports threonine | Upregulated in cancer; potential drug target |
| SLC38A2 | Na+-coupled neutral amino acid transporter, transports threonine | Regulated by osmotic stress; involved in cell growth |
| SLC38A5 | Na+-coupled neutral amino acid transporter, transports threonine | Expressed in brain and placenta; role in nutrient supply |
| SLC3A2 | Heavy chain of amino acid transporters, associates with SLC7A5 etc. | Essential for transporter function; linked to cancer and immune disorders |
| SLC43A1 | L-type amino acid transporter, transports threonine | Expressed in liver and muscle; role in amino acid homeostasis |
| SLC43A2 | L-type amino acid transporter, transports threonine | Involved in T-cell activation and cancer immunity |
| PAT1 (SLC36A1) | Proton-coupled amino acid transporter, transports threonine | Expressed in intestine and lysosomes; role in nutrient sensing |
| SNAT1 (SLC38A1) | System A transporter, transports threonine | Regulated by insulin; involved in neuronal development |
| SNAT2 (SLC38A2) | System A transporter, transports threonine | Adaptive regulation under amino acid stress |
| SNAT4 (SLC38A4) | System A transporter, transports threonine | Expressed in liver; role in fetal development |
| B0AT1 (SLC6A19) | Neutral amino acid transporter, transports threonine | Mutations cause Hartnup disorder; role in intestinal absorption |
| EAAT3 (SLC1A1) | Excitatory amino acid transporter, may transport threonine | Neuronal threonine uptake; linked to OCD and epilepsy |
| TAT1 (SLC16A10) | Aromatic amino acid transporter, may transport threonine | Expressed in kidney and intestine; role in amino acid transport |
| LAT1 (SLC7A5) | L-type amino acid transporter, transports threonine | Target for cancer imaging and therapy |
How Is threonine transport Regulated?
Threonine transport is regulated by various mechanisms to ensure adequate intracellular threonine levels. Post-translational modifications, such as phosphorylation, can rapidly modulate transporter activity. For instance, dephosphorylation of the dopamine transporter at threonine 48 by protein phosphatase PP1/2A up-regulates transport velocity, indicating that phosphorylation at this residue inhibits transport. This regulation links threonine transport to cellular signaling pathways. Additionally, the expression of threonine transporters can be regulated at the transcriptional level in response to nutrient availability, stress, and hormonal signals. In cancer cells, the N-like amino acid transport system for threonine and glutamine is present, suggesting that transporter expression is adapted to support rapid growth. Metabolic pathways controlling skin homeostasis and inflammation may also influence threonine transport to meet the demands of immune cells. Furthermore, the blood-brain barrier threonine transport is likely regulated to maintain brain amino acid homeostasis.
threonine transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC7A5 | Cancer (e.g., lymphoma, glioma) | Knockout in cancer cell lines to assess proliferation and tumor growth |
| SLC6A14 | Cancer (e.g., colon, breast) | Overexpression in normal cells to study oncogenic potential |
| SLC1A1 | Neurological disorders (OCD, epilepsy) | Point mutation in neurons to study transport function |
| SLC6A19 | Hartnup disorder | Knock-in of patient mutations in intestinal cells |
| Porphyromonas gingivalis transporter | Periodontal disease | Knockout in bacterial strains to study virulence |
Threonine Transport in Cancer
Cancer cells often reprogram amino acid transport to support their rapid proliferation and survival. The presence of specific threonine transport systems, such as the N-like system in murine P388 leukemia cells, indicates that cancer cells have increased demands for threonine and glutamine. Overexpression of amino acid transporters like SLC7A5 and SLC6A14 has been observed in various cancers and is associated with poor prognosis. Targeting threonine transport could therefore be a therapeutic strategy to starve cancer cells of essential amino acids. Additionally, threonine transport may influence immune responses in the tumor microenvironment, as metabolic pathways controlling skin homeostasis and inflammation involve threonine.
Threonine Transport and Neurological Disorders
The blood-brain barrier possesses specific transport mechanisms for threonine, which are essential for supplying the brain with this amino acid. Disruptions in threonine transport across the blood-brain barrier could lead to altered neurotransmitter synthesis and neurological dysfunction. For example, threonine is a precursor for glycine and serine, which are neurotransmitters and neuromodulators. Moreover, phosphorylation of the dopamine transporter at threonine 48 regulates its transport velocity, linking threonine transport to dopaminergic signaling. Dysregulation of this process may contribute to neuropsychiatric disorders such as ADHD and depression. Further research into threonine transport in the brain could reveal new therapeutic targets.
Threonine Transport in Infectious Diseases
Bacterial pathogens rely on threonine transport for their growth and virulence. The sodium ion-driven serine/threonine transport system in Porphyromonas gingivalis, a periodontal pathogen, is essential for its survival in the oral cavity. Similarly, Escherichia coli possesses a Na+-coupled serine-threonine transport system that enables it to compete for nutrients in the gut. Inhibiting these bacterial transporters could provide a novel approach to combat infections. Understanding the structural and functional properties of bacterial threonine transporters may facilitate the development of specific inhibitors that do not affect human transporters.
Threonine Transport in Skin Inflammation
Metabolic pathways that control skin homeostasis and inflammation are increasingly recognized as important for immune regulation. Threonine transport may play a role in supplying immune cells in the skin with threonine, which is needed for cytokine production and cell proliferation. Dysregulated threonine transport could contribute to chronic inflammatory skin diseases such as psoriasis and atopic dermatitis. Targeting threonine transporters in skin immune cells might offer new therapeutic avenues for these conditions.
From threonine transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the role of a specific transporter in threonine uptake? | CRISPR knockout of the transporter gene in cell lines, followed by radiolabeled threonine uptake assays |
| How does a point mutation affect transporter function? | CRISPR point mutation (e.g., T48A in DAT) to assess changes in transport velocity |
| Can a transporter be tagged for localization studies? | Knock-in of a fluorescent tag (e.g., GFP) at the endogenous locus |
| What is the effect of transporter overexpression? | CRISPR activation (CRISPRa) or cDNA overexpression in cell lines |
| Which genes are essential for threonine transport under stress? | Genome-wide CRISPR knockout library screening with threonine deprivation |
| How does threonine transport affect brain function? | Conditional knockout in mouse brain endothelial cells followed by behavioral tests |
How to Study the threonine transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled uptake assay | Transport activity and kinetics | Characterizing threonine transport in cells and vesicles |
| Membrane vesicle transport | Transport across isolated membranes | Studying ion dependence and substrate specificity |
| Electrophysiology | Electrogenic transport currents | Determining stoichiometry and voltage dependence |
| CRISPR knockout screen | Genes essential for threonine transport | Identifying novel transporters or regulators |
| CRISPR activation screen | Genes that enhance threonine transport | Finding rate-limiting components |
| Proteomics | Protein expression and interactions | Identifying transporter complexes |
| Imaging (fluorescent tags) | Subcellular localization of transporters | Tracking transporter trafficking |
| RNA-seq | Transcriptional changes in response to threonine availability | Identifying regulated transporters |
Radiolabeled Threonine Uptake Assays
Radiolabeled threonine uptake assays are a classic method to measure transport activity. Cells or membrane vesicles are incubated with [3H]- or [14C]-labeled threonine, and the amount of radioactivity internalized is quantified. This technique has been used to characterize threonine transport in murine P388 leukemia cells and pig jejunal brush border membrane vesicles. The assay can be adapted to study kinetics, substrate specificity, and the effects of inhibitors. It is highly sensitive and can be performed in high-throughput formats for screening purposes.
Membrane Vesicle Transport Studies
Membrane vesicle transport studies use isolated membrane vesicles to study transport in a controlled environment. For example, brush border membrane vesicles from pig jejunum were used to functionally characterize system B for threonine transport. This method allows researchers to dissect the driving forces (e.g., ion gradients) and kinetics of transport without interference from cellular metabolism. It is particularly useful for studying transporters in epithelial tissues and for identifying novel transport systems.
Electrophysiological Measurements
Electrophysiological techniques, such as two-electrode voltage clamp or patch clamp, can measure the electrical currents associated with electrogenic threonine transport. This is applicable to Na+-coupled transporters that translocate net charge. For instance, the Na+-coupled serine/threonine transport system in E. coli could be studied using electrophysiology after reconstitution into lipid bilayers. This method provides real-time information on transport stoichiometry and voltage dependence.
CRISPR-Cas9 Genetic Screens
CRISPR-Cas9 genetic screens are powerful tools to identify genes involved in threonine transport. A genome-wide knockout library can be screened under threonine-limiting conditions to find transporters or regulatory genes essential for survival. This approach has been used to uncover metabolic vulnerabilities in cancer cells. Similarly, CRISPR activation screens can identify genes whose overexpression enhances threonine uptake. These screens can be combined with next-generation sequencing to quantify guide RNA enrichment, providing a comprehensive list of candidate genes.
How CRISPR Can Be Used to Study GO:0015826 threonine transport
Knockout
CRISPR knockout is used to completely abolish the function of a candidate threonine transporter gene to assess its contribution to overall threonine uptake. For example, knocking out SLC7A5 in cancer cells can reduce threonine transport and inhibit proliferation. Knockout models are essential for validating the specificity of transport inhibitors and for identifying compensatory mechanisms. In bacteria, knockout of the Na+-coupled serine/threonine transporter in Porphyromonas gingivalis can attenuate virulence.
Point Mutation
CRISPR point mutation allows the introduction of specific amino acid substitutions to study structure-function relationships. For instance, mutating threonine 48 in the dopamine transporter to alanine (T48A) can mimic dephosphorylation and up-regulate transport velocity. Point mutations can also be used to disrupt ion coupling or substrate binding. This approach is valuable for dissecting the molecular determinants of threonine transport and for modeling human genetic variants.
Knock-in
CRISPR knock-in enables the insertion of tags (e.g., GFP, HA) or reporter genes at the endogenous locus of a threonine transporter. This allows real-time visualization of transporter localization and trafficking in live cells. Knock-in of disease-associated mutations can also create isogenic models to study the impact on transport function. For example, knocking in a patient mutation in SLC6A19 can model Hartnup disorder in intestinal cells.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression is used to increase the expression of a threonine transporter to study its effects on cellular metabolism and signaling. Overexpression of SLC7A5 in cancer cells can enhance threonine uptake and activate mTOR signaling. This approach is useful for identifying downstream pathways and for testing whether increased transport is sufficient to drive phenotypes such as proliferation or drug resistance.
How EDITGENE Supports threonine transport Research
Researchers studying threonine transport-related genes often need to determine whether a candidate gene is causally involved in the transport process, how mutations affect transporter function, and what downstream pathways are impacted. EDITGENE provides a comprehensive suite of CRISPR-based services to address these questions, from generating knockout cell lines to performing genome-wide screens and bioinformatics analysis.
Contact EDITGENE today to design your custom CRISPR model for threonine transport research.
Frequently Asked Questions About threonine transport
What is threonine transport?
Threonine transport is the biological process of moving the amino acid threonine across cell membranes, mediated by specific transporter proteins, as defined by GO:0015826.
What genes are involved in threonine transport?
Genes encoding amino acid transporters such as SLC7A5, SLC6A14, SLC1A5, and SLC38A2 are involved in threonine transport, along with bacterial systems like the Na+-coupled serine/threonine transporter.
How is threonine transport regulated?
Threonine transport can be regulated by phosphorylation, as shown for the dopamine transporter where dephosphorylation at threonine 48 increases transport velocity. It can also be regulated at the transcriptional level in response to nutrient availability.
Why is threonine transport important for cancer?
Cancer cells often upregulate threonine transporters to support rapid growth, and targeting these transporters may inhibit tumor proliferation.
What is the role of threonine transport in the brain?
Threonine transport across the blood-brain barrier supplies the brain with threonine, which is needed for neurotransmitter synthesis and brain function.
How can I study threonine transport using CRISPR?
CRISPR can be used to knockout, mutate, or tag threonine transporter genes to study their function, localization, and regulation in cellular models.
What diseases are associated with defective threonine transport?
Defective threonine transport has been linked to cancer, neurological disorders, and infectious diseases, though direct causal mutations are still being investigated.
What methods are used to measure threonine transport?
Common methods include radiolabeled threonine uptake assays, membrane vesicle transport studies, and electrophysiological measurements.
Are there specific inhibitors of threonine transporters?
Some inhibitors exist for amino acid transporters, but specific threonine transport inhibitors are still under development; bacterial transporters are potential targets.
How does threonine transport differ between organisms?
Threonine transport systems vary; bacteria often use Na+-coupled symporters, while mammalian cells use facilitated diffusion or Na+-dependent transporters with different substrate specificities.
Conclusion
Threonine transport (GO:0015826) is a fundamental biological process that ensures the supply of the essential amino acid threonine to cells. It is mediated by a diverse array of transporter proteins with specific tissue distributions and regulatory mechanisms. Dysregulation of threonine transport is implicated in cancer, neurological disorders, and infectious diseases, making it a promising target for therapeutic intervention. Advances in CRISPR-based genetic models and screening technologies are poised to accelerate the discovery of novel transporters and regulatory pathways, providing new insights into cellular metabolism and disease. EDITGENE's comprehensive services support researchers in dissecting the molecular details of threonine transport and translating these findings into clinical applications.
References
- 1. Cibrian D et al.. 2020. Metabolic Pathways That Control Skin Homeostasis and Inflammation.. Trends Mol Med 26(11):975-986 PMID: 32371170
- 3. Tovar A et al.. 1988. Some characteristics of threonine transport across the blood-brain barrier of the rat.. J Neurochem 51(4):1285-93 PMID: 3138388
- 4. Dashper SG et al.. 2001. Sodium ion-driven serine/threonine transport in Porphyromonas gingivalis.. J Bacteriol 183(14):4142-8 PMID: 11418553
- 5. Yang JW et al.. 2019. Dephosphorylation of human dopamine transporter at threonine 48 by protein phosphatase PP1/2A up-regulates transport velocity.. J Biol Chem 294(10):3419-3431 PMID: 30587577
- 6. Lazarus P et al.. 1986. Characterization of L-threonine and L-glutamine transport in murine P388 leukemia cells in vitro. Presence of an N-like amino acid transport system.. Biochim Biophys Acta 856(3):488-95 PMID: 3083865
- 7. Hama H et al.. 1987. Properties of a Na+-coupled serine-threonine transport system in Escherichia coli.. Biochim Biophys Acta 905(2):231-9 PMID: 2825778
- 8. Maenz DD et al.. 1992. L-threonine transport in pig jejunal brush border membrane vesicles. Functional characterization of the unique system B in the intestinal epithelium.. J Biol Chem 267(31):22079-86 PMID: 1429560
